The C-terminal region of <it>Bfl-1 </it>sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing <it>NF-κB </it>activity and down-regulating Bfl-1

<p>Abstract</p> <p>Gemcitabine is used to treat several cancers including lung cancer. However, tumor cells often escape gemcitabine-induced cell death via various mechanisms, which include modulating bcl-2 family members and NF-κB activation. We previously reported that the C-terminal region of Bfl...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Kim Min-Kyoung, Jeon Yoon-Kyung, Woo Jong-Kyu, Choi Yun, Choi Dae-Han, Kim Yeul-Hong, Kim Chul-Woo
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2011-08-01
Σειρά:	Molecular Cancer
Θέματα:	gemcitabine NF-κB Bfl-1 gene therapy non-small cell lung cancer
Διαθέσιμο Online:	http://www.molecular-cancer.com/content/10/1/98
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!